Avanos Medical (AVNS) Change in Receivables (2013 - 2026)

Avanos Medical has disclosed Change in Receivables across 14 years of filings, most recently posting $300000.0 for Q1 2026.

• Change in Receivables for Q1 2026 came in at $300000.0, up 101.2% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.5 million (up 46.6% YoY), and the FY2025 annual result was -$30.9 million, down 568.18% from the prior year.
• Change in Receivables came in at $300000.0 for Q1 2026 at Avanos Medical, up from -$8.1 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $18.7 million in Q4 2022 to a low of -$26.2 million in Q1 2023.
• The 5-year median for Change in Receivables is -$700000.0 (2025), against an average of -$2.3 million.
• Across the five-year window, Change in Receivables soared 6133.33% in 2022 and sank 2600.0% in 2025, its largest moves.
• Avanos Medical's Change in Receivables stood at $18.7 million in 2022, then sank by 148.13% to -$9.0 million in 2023, then jumped by 96.67% to -$300000.0 in 2024, then tumbled by 2600.0% to -$8.1 million in 2025, then surged by 103.7% to $300000.0 in 2026.
• The last three Change in Receivables figures came in at $300000.0 (Q1 2026), -$8.1 million (Q4 2025), and -$700000.0 (Q3 2025), per Business Quant data.